Correlation Between Grupo Televisa and Acumen Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Grupo Televisa and Acumen Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Grupo Televisa and Acumen Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Grupo Televisa SAB and Acumen Pharmaceuticals, you can compare the effects of market volatilities on Grupo Televisa and Acumen Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Grupo Televisa with a short position of Acumen Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Grupo Televisa and Acumen Pharmaceuticals.
Diversification Opportunities for Grupo Televisa and Acumen Pharmaceuticals
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Grupo and Acumen is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Grupo Televisa SAB and Acumen Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acumen Pharmaceuticals and Grupo Televisa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Grupo Televisa SAB are associated (or correlated) with Acumen Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acumen Pharmaceuticals has no effect on the direction of Grupo Televisa i.e., Grupo Televisa and Acumen Pharmaceuticals go up and down completely randomly.
Pair Corralation between Grupo Televisa and Acumen Pharmaceuticals
Allowing for the 90-day total investment horizon Grupo Televisa SAB is expected to under-perform the Acumen Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Grupo Televisa SAB is 1.49 times less risky than Acumen Pharmaceuticals. The stock trades about -0.08 of its potential returns per unit of risk. The Acumen Pharmaceuticals is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 258.00 in Acumen Pharmaceuticals on September 3, 2024 and sell it today you would lose (31.00) from holding Acumen Pharmaceuticals or give up 12.02% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Grupo Televisa SAB vs. Acumen Pharmaceuticals
Performance |
| Timeline |
| Grupo Televisa SAB |
| Acumen Pharmaceuticals |
Grupo Televisa and Acumen Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Grupo Televisa and Acumen Pharmaceuticals
The main advantage of trading using opposite Grupo Televisa and Acumen Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Grupo Televisa position performs unexpectedly, Acumen Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acumen Pharmaceuticals will offset losses from the drop in Acumen Pharmaceuticals' long position.| Grupo Televisa vs. Orange SA ADR | Grupo Televisa vs. Telefonica Brasil SA | Grupo Televisa vs. Telefonica SA ADR | Grupo Televisa vs. Liberty Broadband Srs |
| Acumen Pharmaceuticals vs. DiaMedica Therapeutics | Acumen Pharmaceuticals vs. Lyra Therapeutics | Acumen Pharmaceuticals vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |